C-Rad AB (publ) (STO:CRAD.B)
34.30
0.00 (0.00%)
May 25, 2026, 4:18 PM CET
C-Rad AB Market Cap
C-Rad AB has a market cap or net worth of 1.18 billion as of May 22, 2026. Its market cap has increased by 11.91% in one year.
Market Cap
1.18B
Enterprise Value
1.06B
Revenue
427.80M
Ranking
n/a
PE Ratio
39.77
Stock Price
34.30
Market Cap Chart
Since July 23, 2007, C-Rad AB's market cap has increased from 65.86M to 1.18B, an increase of 1,694.35%. That is a compound annual growth rate of 16.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 22, 2026 | 1.16B | 7.96% |
| Dec 30, 2025 | 1.07B | 6.50% |
| Dec 30, 2024 | 1.01B | -29.12% |
| Dec 29, 2023 | 1.42B | 10.47% |
| Dec 30, 2022 | 1.29B | -31.57% |
| Dec 30, 2021 | 1.88B | 15.88% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CellaVision AB | 2.91B |
| Devyser Diagnostics AB | 1.62B |
| BICO Group AB | 1.33B |
| Paxman AB | 1.19B |
| Sedana Medical AB | 978.47M |
| Senzime AB | 728.69M |
| Episurf Medical AB | 726.32M |
| Bactiguard Holding AB | 560.70M |